The cost-effectiveness of different management strategies for patients on chronic warfarin therapy.
about
Is self-monitoring an effective option for people receiving long-term vitamin K antagonist therapy? A systematic review and economic evaluationPatient time requirements for anticoagulation therapy with warfarin.Patients' perspectives on self-testing of oral anticoagulation therapy: content analysis of patients' internet blogsThe impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature.Dabigatran versus warfarin under standard or pharmacogenetic-guided management for the prevention of stroke and systemic thromboembolism in patients with atrial fibrillation: a cost/utility analysis using an analytic decision model.Nurses' self-reported time estimation of anticoagulation therapy: a survey of warfarin management in long-term care.Management of Chinese patients on warfarin therapy in two models of anticoagulation service - a prospective randomized trial.Is dabigatran considered a cost-effective alternative to warfarin treatment: a review of current economic evaluations worldwideEconomic implications of nonadherence to highly active antiretroviral treatment in HIV patients.Cost-Effectiveness of Dabigatran (150 mg Twice Daily) and Warfarin in Patients ≥ 65 Years With Nonvalvular Atrial FibrillationMassachusetts Health Reform Cost Less and Was More Effective for Uninsured Individuals With Venous Thromboembolism: A Cost-Effectiveness Analysis.Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III.Economic impact of poor compliance with pharmaceuticals.Penny-wise, pound-foolish? Highmark Medicare Services' proposal for anticoagulation clinic reimbursement.Comparing clinicians' use of an anticoagulation management service and usual care in ambulatory oncology.The role of anticoagulation clinics in the era of new oral anticoagulants.The best of JGIM.Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.Cost effectiveness of apixaban versus aspirin for stroke prevention in patients with non-valvular atrial fibrillation in Belgium.Potential clinical and economic outcomes of CYP2C9 and VKORC1 genotype-guided dosing in patients starting warfarin therapy.Technology-assisted self-testing and management of oral anticoagulation therapy: a qualitative patient-focused study.Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care.
P2860
Q28081070-CDCA7993-2A27-46D2-8825-3F323B7FA155Q33505924-404D92A9-9898-4F30-885E-4BE227755ACBQ33811298-5CB5776A-8520-41C7-91B5-9635D4843C45Q34464972-E0589B61-9FC1-4432-8EC4-8301B9D7AF9AQ34834319-EC2F48B2-16FE-4D63-B30B-56BD9E809584Q35108548-CD99111F-ADF2-4416-832F-BAA14090B3F8Q35827850-672FBE99-E2AC-4DAA-85FE-08A0F07E6316Q36232280-1BC03391-9A92-4880-8293-8C020A1A5785Q36376395-012975DD-E611-4E0D-BBED-A77B58DED13DQ36657598-23ACDFED-2376-46FD-AAAD-D96485864AAAQ36803506-08C70D95-7695-483E-9163-62A01F6F2CD2Q37523123-002CD561-3057-49A7-BA79-4EE95682C8DBQ37609268-80F6E23F-5F3B-487C-9BE4-F184F18BD049Q37717892-F885FBE5-37BA-4736-9879-1601E0AA84A9Q38061872-F0EA246C-F7D4-4BBF-897B-DFBDA74C4779Q39530702-34B67651-09DD-42FB-8BD0-EAF0DB45ED56Q42347667-EBA44CE2-CAF8-4C15-B5CD-D8C15B7BAEE1Q43774366-C5B81DF6-0088-4466-AE72-BEB57AE155DCQ44316111-68E8C292-1D70-4073-BFFD-603693CA921BQ45942815-2781587C-F02D-4412-A35F-BDBB3BB595BCQ47407486-142C7092-60EC-490D-AC2A-7989465BDD91Q51008130-6A4E9BF0-D521-47EC-97F9-FE2C48F70464
P2860
The cost-effectiveness of different management strategies for patients on chronic warfarin therapy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The cost-effectiveness of diff ...... s on chronic warfarin therapy.
@ast
The cost-effectiveness of diff ...... s on chronic warfarin therapy.
@en
The cost-effectiveness of diff ...... s on chronic warfarin therapy.
@nl
type
label
The cost-effectiveness of diff ...... s on chronic warfarin therapy.
@ast
The cost-effectiveness of diff ...... s on chronic warfarin therapy.
@en
The cost-effectiveness of diff ...... s on chronic warfarin therapy.
@nl
prefLabel
The cost-effectiveness of diff ...... s on chronic warfarin therapy.
@ast
The cost-effectiveness of diff ...... s on chronic warfarin therapy.
@en
The cost-effectiveness of diff ...... s on chronic warfarin therapy.
@nl
P2093
P2860
P1476
The cost-effectiveness of diff ...... s on chronic warfarin therapy.
@en
P2093
P2860
P356
10.1046/J.1525-1497.2000.01239.X
P577
2000-01-01T00:00:00Z
P5875
P6179
1034298624